Kronox Lab Sciences Approves Unaudited Financial Results for Quarter Ended Sep 30, 2025
Kronox Lab Sciences approved standalone unaudited financial results for the quarter and half year ended 30 September 2025. Total income for the quarter was ₹2,515.97 lakhs and profit after tax was ₹624.21 lakhs.
The announcement provides details on the company's financial performance, which is relevant to investors. The details of the dividend payout also add to the impact.
The announcement conveys the approval of financial results, showing positive financial performance for the quarter and half-year ended September 30, 2025. The results indicate growth and profitability.
* Approved standalone unaudited financial results for the quarter and half year ended 30 September 2025. * Reviewed by the Statutory Auditors and approved by the Board of Directors on 11 November 2025. * Total Income for the quarter ended September 30, 2025, was ₹2,515.97 lakhs. * Total Income for the half year ended September 30, 2025, was ₹5,173.50 lakhs. * Profit after Tax for the quarter was ₹624.21 lakhs. * Profit after Tax for the half year was ₹1,306.69 lakhs. * The company had given Final Dividend @ 5% for the FY 24-25 In the month of September 2025.
What to do with a filing like this
Kronox Lab Sciences Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Kronox Lab Sciences Limited. Read the original for the full detail.